Literature DB >> 8690163

Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr).

S C Chua1, D W White, X S Wu-Peng, S M Liu, N Okada, E E Kershaw, W K Chung, L Power-Kehoe, M Chua, L A Tartaglia, R L Leibel.   

Abstract

The rat fatty (fa) mutation produces profound obesity of early onset caused by hyperphagia, defective nonshivering thermogenesis, and preferential deposition of energy into adipose tissue. Genetic mapping studies indicate that fa and diabetes (db) are homologous loci in the rat and mouse genomes, respectively. It has been shown that db alleles carry mutations in the Lepr (leptin receptor) gene. This paper describes a point mutation in the fatty allele of Lepr. A nucleotide substitution at position 880 (A-->C) causes an amino acid substitution at position 269 (Gln-->Pro). The mutation generates a novel Msp I site that cosegregates with fa in 1,028 meioses examined in obese F2 progeny from two crosses (Bnx13M and WKYx13M) and is still segregating in three rat colonies. PCR-based mutagenesis was used to introduce the fa mutation into the mouse Lepr cDNA. Transient transfection studies indicate that the mutant Lepr cDNA has greatly reduced binding of leptin (Lep) at the cell surface. These data are strong evidence that the single nucleotide substitution in the fa allele of Lepr (Leprfa) is responsible for the obese phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690163     DOI: 10.2337/diab.45.8.1141

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  56 in total

Review 1.  Hypothalamic inflammation and thermogenesis: the brown adipose tissue connection.

Authors:  Ana Paula Arruda; Marciane Milanski; Licio A Velloso
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

Review 2.  Sleep and obesity: a focus on animal models.

Authors:  Vijayakumar Mavanji; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Neurosci Biobehav Rev       Date:  2012-01-16       Impact factor: 8.989

3.  Rapid inhibition of neurons in the dorsal motor nucleus of the vagus by leptin.

Authors:  K W Williams; A Zsombok; B N Smith
Journal:  Endocrinology       Date:  2006-12-28       Impact factor: 4.736

4.  Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism.

Authors:  Songbai Lin; Neeraj K Saxena; Xiaokun Ding; Lance L Stein; Frank A Anania
Journal:  Mol Endocrinol       Date:  2006-08-24

5.  Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure.

Authors:  Helge Müller-Fielitz; Antonie Markert; Christian Wittmershaus; Friedrich Pahlke; Olaf Jöhren; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-03       Impact factor: 3.000

6.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

Review 7.  Leptin: at the crossroads of energy balance and systemic inflammation.

Authors:  Alexandre A Steiner; Andrej A Romanovsky
Journal:  Prog Lipid Res       Date:  2006-12-21       Impact factor: 16.195

8.  Rapid inhibition of neural excitability in the nucleus tractus solitarii by leptin: implications for ingestive behaviour.

Authors:  K W Williams; B N Smith
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

9.  Overexpression of gastric leptin precedes adipocyte leptin during high-fat diet and is linked to 5HT-containing enterochromaffin cells.

Authors:  J Le Beyec; A-L Pelletier; K Arapis; M Hourseau; F Cluzeaud; V Descatoire; R Ducroc; T Aparicio; F Joly; A Couvelard; J-P Marmuse; M Le Gall; A Bado
Journal:  Int J Obes (Lond)       Date:  2014-01-28       Impact factor: 5.095

Review 10.  Leptin and obesity in humans.

Authors:  R V Considine
Journal:  Eat Weight Disord       Date:  1997-06       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.